Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet)

Clinical Trial: Probiotics in Metformin Intolerant Patients with Type 2 Diabetes (ProGasMet)

Background: For decades, metformin has been the drug of first choice in the management of type 2 diabetes. However, approximately 2–13% of patients do not tolerate metformin due to gastrointestinal (GI) side effects. Since metformin influences the gut microbiota, we hypothesized that a multi-strain...

Full description

Bibliographic Details
Main Authors: Katarzyna Nabrdalik, Karolina Drożdż, Hanna Kwiendacz, Karolina Skonieczna-Żydecka, Igor Łoniewski, Mariusz Kaczmarczyk, Agata M. Wijata, Jakub Nalepa, Frits Holleman, Max Nieuwdorp, Janusz Gumprecht
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Diabetes mellitus type 2
Metformin intolerance
Probiotics
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223014488

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223014488

Similar Items